We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
-13.17%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
10 Year Est. Return
AUM
$4.31B
AUM Growth
-$768M
Cap. Flow
-$24.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
22.74%
Holding
1,425
New
109
Increased
486
Reduced
323
Closed
110

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$38.9M
2
COP icon
ConocoPhillips
COP
+$22.8M
3
LIN icon
Linde
LIN
+$21.7M
4
XOM icon
ExxonMobil
XOM
+$19.2M
5
MRK icon
Merck
MRK
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 18.23%
2 Healthcare 15.18%
3 Financials 14.65%
4 Consumer Discretionary 13.31%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARNA
1301
DELISTED
Arena Pharmaceuticals Inc
ARNA
$10K ﹤0.01%
+264
New +$10.4K
CLDR
1302
DELISTED
Cloudera, Inc.
CLDR
$10K ﹤0.01%
+944
New +$12.6K
ELLI
1303
DELISTED
Ellie Mae Inc
ELLI
$10K ﹤0.01%
+160
New +$11.4K
TBPH icon
1304
Theravance Biopharma
TBPH
$878M
$9K ﹤0.01%
+352
New +$9.5K
MDGL icon
1305
Madrigal Pharmaceuticals
MDGL
$12.4B
$6K ﹤0.01%
+56
New +$8.67K
SCG
1306
DELISTED
Scana
SCG
$5K ﹤0.01%
112
-784
-88% -$33.7K
ESLT icon
1307
Elbit Systems
ESLT
$36.5B
$4K ﹤0.01%
+32
New +$3.88K
TARA icon
1308
Protara Therapeutics
TARA
$219M
$4K ﹤0.01%
+47
New +$3.32K
ARRY
1309
DELISTED
Array Biopharma Inc
ARRY
$4K ﹤0.01%
+264
New +$4K
SRRK icon
1310
Scholar Rock
SRRK
$6.55B
$3K ﹤0.01%
+140
New +$3.17K
TPST icon
1311
Tempest Therapeutics
TPST
$19.3M
$3K ﹤0.01%
2
+1
+100% +$2.06K
PTGX icon
1312
Protagonist Therapeutics
PTGX
$9.84B
$2K ﹤0.01%
+286
New +$2.27K
EIGR
1313
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2K ﹤0.01%
+7
New +$2.26K
ARVN icon
1314
Arvinas
ARVN
$580M
$1K ﹤0.01%
+110
New +$1.75K
PTE
1315
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1K ﹤0.01%
+4
New +$1.45K
AEG icon
1316
Aegon
AEG
$13.9B
-51,677
Closed -$285K
ASRT
1317
DELISTED
Assertio
ASRT
-178
Closed -$63K
BBVA icon
1318
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
-61,852
Closed -$390K
BGFV
1319
DELISTED
Big 5 Sporting Goods
BGFV
-3,184
Closed -$16K
BHP icon
1320
BHP
BHP
$229B
-15,748
Closed -$700K
BILI icon
1321
Bilibili
BILI
$7.37B
-10,428
Closed -$141K
BLUE
1322
DELISTED
bluebird bio
BLUE
-372
Closed -$703K
BP icon
1323
BP
BP
$111B
-12,728
Closed -$560K
BTE icon
1324
Baytex Energy
BTE
$3.05B
-2,108
Closed -$6K
CE icon
1325
Celanese
CE
$4.75B
-700
Closed -$80K

Similar funds

Meadow Creek Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Meadow Creek Investment Management held 1,425 positions worth $4.31B, down 15% from $5.08B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q4 2018 filing shows 109 new, 486 increased, 323 reduced and 110 closed positions. Its largest new stake was Linde: 137,592 shares worth $21.5M. The largest sale was Express Scripts Holding Company, an estimated $65.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Meadow Creek Investment Management's largest Q4 2018 buy was Linde: 137,592 shares worth $21.5M.
  • Meadow Creek Investment Management added most to Cigna in Q4 2018, an estimated $38.9M increase.
  • Meadow Creek Investment Management's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $20.9M.
  • Meadow Creek Investment Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $65.1M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $4.31B portfolio in Q4 2018.
  • Meadow Creek Investment Management opened 109 new positions and closed 110 in Q4 2018.
  • Meadow Creek Investment Management's portfolio value fell 15% quarter-over-quarter to $4.31B.

Based on Meadow Creek Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.